Kales A, Kales JD: Evaluation, diagnosis and treatment of clinical conditions related to sleep . JAMA 213:2229-2235, 1970;.
Kales A, et al: Hypnotic drugs and their effectiveness: All night EEG studies of insomniac subjects . Arch Gen Psychiatry 23:226-232, 1970;.
Kales A, Cary G: Insomnia, evaluation, and treatment , in Robins E (ed): Psychiatry (suppl to Medical World News) , pp 55-56, 1971;.
Kales A, et al: Psychological evaluation and treatment studies of insomniac subjects . Psychophysiology 9:137, 1972;.
Rechtschaffen A, Kales A (eds): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects, publication 204. Public Health Service Publications, US Government Printing Office, 1968.
Kales A, et al: All night sleep studies in hypothyroid patients, before and after treatment . J Clin Endocrinol Metab 27:1593-1599, 1967;.
Kales A, et al: Hypnotics and altered sleep-dream patterns: II. All night EEG studies of chloral hydrate, flurazepam, and methaqualone . Arch Gen Psychiatry 23:219-225, 1970;.
Kales A, et al: Hypnotics and altered sleep-dream patterns: I. All night EEG studies of glutethimide, methyprylon, and pentobarbital . Arch Gen Psychiatry 23:211-218, 1970;.
Wyatt R, et al: Longitudinal studies of the effects of monoamine oxidase inhibitors on sleep in man . Psychopharmacologia 15:236-244, 1969;.
Oswald I, Priest RG: Five weeks to escape the sleeping pill habit . Br Med J 2:1093-1099, 1965;.
Oswald I, Thacore VR: Amphetamine and phenmetrazine addiction: Physiological abnormalities in the abstinence syndrome . Br Med J 2:427, 1963;.
Kales A, et al: Psychophysiological and biochemical changes following use and withdrawal of hypnotics , in Kales A (ed): Sleep: Physiology and Pathology . Philadelphia, JP Lippincott Co, pp 331-343, 1969;.
Kales A, et al: Sleep laboratory effectiveness studies of secobarbital and methaqualone . Read before the 74th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, New Orleans, 1973 .
Food and Drug Administration Guidelines for the Evaluation of New Hypnotic Drugs . Prepared by a joint committee of the Pharmaceutical Manufacturers Association and the Food and Drug Administration, 1971;.